Chandler H. Park, MD, FACP
Articles by Chandler H. Park, MD, FACP
Autologous Stem Cell Transplantation in Multiple Myeloma: Is It Still the Gold Standard?
ByTaha Kassim Dohadwala, MS5,Jenna Ghazal, BSc,Soumiya Nadar, MS5,Riya Vaishnav, MBBS,Ishan Paduvagere,Viviana Cortiana, MS4,Chandler H. Park, MD, FACP,Yan Leyfman, MD Discover how stem cell transplant still deepens myeloma remission, guided by MRD and paired with CAR‑T, bispecifics, and smarter maintenance.
Artificial Intelligence in Cancer Care: Addressing Challenges and Health Equity
ByViviana Cortiana, MS4,Kennedy Itodo, BS,Yan Leyfman, MD,Jenna Ghazal, BSc,Vraj JigarKumar Rangrej, MBBS,Adhith Theyver,Chandler H. Park, MD, FACP Artificial intelligence may mitigate overdiagnosis and unnecessary treatments in cancer care by integrating with precision medicine.
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies
ByViviana Cortlana, MS4,Jade Gambill, BS,Jenna Ghazal, BSc,Kennedy Itodo,Shreevikaa Kannan, PGY-5,Yan Leyfman, MD,Chandler H. Park, MD, FACP Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.
